Anti-norovirus therapeutics: a patent review (2010-2015)
- 25 February 2016
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 26 (3) , 297-308
Abstract
(2016). Anti-norovirus therapeutics: a patent review (2010-2015) Expert Opinion on Therapeutic Patents: Vol. 26, No. 3, pp. 297-308.Keywords
Funding Information
- National Institute of Health (NIH) (AI109039)
This publication has 97 references indexed in Scilit:
- Synthesis and anti-norovirus activity of pyranobenzopyrone compoundsBioorganic & Medicinal Chemistry Letters, 2012
- Characterization and inhibition of norovirus proteases of genogroups I and II using a fluorescence resonance energy transfer assayVirology, 2012
- Cyclosulfamide-based derivatives as inhibitors of norovirusesEuropean Journal of Medicinal Chemistry, 2012
- Inhibition of noroviruses by piperazine derivativesBioorganic & Medicinal Chemistry Letters, 2012
- Norovirus gastroenteritis successfully treated with nitazoxanideJournal of Infection, 2011
- Potent inhibition of Norwalk virus by cyclic sulfamide derivativesBioorganic & Medicinal Chemistry, 2011
- Design and synthesis of inhibitors of noroviruses by scaffold hoppingBioorganic & Medicinal Chemistry, 2011
- Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C proteaseBioorganic & Medicinal Chemistry Letters, 2011
- A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide InhibitorBiochemistry, 2010
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004